“Live Life to Its Full Potential.”
Dr. Amin Abujoub is a globally respected biotechnology and gene therapy executive whose career has been defined by operational excellence, scientific rigor, and transformational leadership across some of the world’s most complex and highly regulated healthcare environments. With more than three decades of professional experience spanning biologics manufacturing, technical operations, quality systems, regulatory strategy, clinical development, and global supply chain management, Dr. Abujoub has built a reputation as a trusted executive capable of guiding organizations through periods of rapid growth, commercialization, and organizational transformation. Throughout his career, he has consistently demonstrated the ability to bridge scientific innovation with operational execution while maintaining an unwavering commitment to quality, compliance, and patient safety.
Currently serving as Chief Technical Operations Officer at uniQure, a pioneering gene therapy company, Dr. Abujoub oversees enterprise-wide technical operations and strategic CMC development supporting transformative therapies for severe genetic diseases. In this role, he partners closely with executive leadership and board stakeholders to ensure operational readiness across manufacturing, quality, process development, and regulatory engagement. His leadership has played a critical role in strengthening the company’s global infrastructure while supporting the transition of programs from research and clinical development into scalable commercial operations. By aligning operational strategy with long-term business objectives, he has helped position the organization for sustainable growth within the rapidly evolving gene therapy sector.
Prior to becoming Chief Technical Operations Officer, Dr. Abujoub served as Chief Quality Officer and Senior Vice President of Global Quality at uniQure, where he led significant enterprise quality transformation initiatives. He was instrumental in developing and implementing the company’s Global Strategic Quality Plan, helping establish a culture of accountability, compliance, and continuous improvement across the organization. Under his leadership, uniQure enhanced inspection readiness efforts for major regulatory filings while transitioning from a paper-based quality management system to a modern, scalable electronic quality platform. These initiatives not only strengthened operational efficiencies but also significantly reduced organizational risk associated with commercialization and regulatory oversight.
Before joining uniQure, Dr. Abujoub served as Senior Vice President of Global Quality at Intercept Pharmaceuticals, where he was tasked with modernizing and scaling the company’s quality systems in preparation for commercial expansion. His ability to quickly build high-performing teams and implement strategic quality frameworks proved instrumental in positioning the company for long-term operational success. During this period, he worked extensively with executive leadership to establish inspection readiness strategies, oversee global GXP compliance, and strengthen relationships with regulatory agencies and manufacturing partners worldwide. His work at Intercept reinforced his reputation as an executive capable of stabilizing and elevating organizations navigating critical stages of growth.
A substantial portion of Dr. Abujoub’s career was shaped during his nearly two-decade tenure at Biogen, where he held multiple senior leadership positions of increasing responsibility. Throughout his time at Biogen, he led organizations supporting global quality operations, clinical drug supply, quality control, CMC program management, and manufacturing oversight. As Vice President of Global Quality Operations, he directed quality oversight for internal and external manufacturing operations supporting drug substance, drug product, finished goods, and global distribution activities. He also led commissioning and validation activities for Biogen’s next-generation manufacturing facility, ensuring inspection readiness and compliance with evolving regulatory expectations.
Earlier in his Biogen career, Dr. Abujoub served as Vice President of Global Quality Control, where he managed a global organization responsible for analytical testing compliance supporting both commercial and clinical programs. In this role, he oversaw large multidisciplinary teams consisting of directors, scientists, and technical specialists responsible for ensuring product purity, efficacy, and regulatory compliance. One of his most notable achievements during this period was designing and leading the company’s “QC Lab of the Future” initiative, an innovation-focused strategy that modernized quality control operations and improved efficiency across global testing laboratories. His leadership consistently reflected a forward-thinking mindset focused on innovation, scalability, and operational resilience.
Dr. Abujoub also made a substantial impact in the areas of clinical supply and CMC strategy. As Senior Director and Director of Global Clinical Drug Supply, he managed clinical supply strategies and manufacturing operations supporting multiple concurrent pivotal trials while overseeing budgets exceeding $100 million. His ability to align supply chain operations with clinical timelines ensured uninterrupted support for complex global studies. In parallel, his leadership in CMC Program Management positioned him at the center of major regulatory initiatives involving agencies such as the FDA, EMA, PMDA, TGA, SwissMedic, and other international regulatory authorities. These experiences gave him a uniquely global perspective on operational risk management, regulatory strategy, and commercialization planning.
Scientifically, Dr. Abujoub’s background is deeply rooted in molecular biology, virology, assay development, and viral clearance technologies. His early career focused on viral safety testing, assay development, and regulatory support for biologics manufacturing and gene therapy applications. Over time, his technical expertise expanded into broader operational leadership, allowing him to lead organizations at the intersection of science, manufacturing, compliance, and strategic execution. His comprehensive understanding of both upstream and downstream biologics manufacturing processes has made him an invaluable leader in organizations operating within highly complex scientific and regulatory environments.
In addition to his technical and operational accomplishments, Dr. Abujoub is widely recognized for his leadership philosophy and commitment to organizational development. Throughout his career, he has built and mentored high-performing teams while fostering cultures centered around accountability, integrity, and continuous improvement. He has successfully led organizations ranging from small specialized scientific groups to large global teams consisting of hundreds of professionals across multiple disciplines and geographies. Colleagues consistently describe him as a thoughtful, disciplined, and empowering leader who balances strategic vision with operational detail while inspiring teams to exceed expectations.
Dr. Abujoub’s international exposure and multicultural perspective have further strengthened his leadership profile. Fluent in both English and Arabic, he has worked extensively with global regulatory agencies, international manufacturing partners, and multinational leadership teams. His experience navigating complex global business environments has enabled him to build collaborative relationships across cultures while maintaining a strong focus on operational excellence and patient outcomes. This global perspective continues to shape his leadership approach and his ability to guide organizations operating in increasingly interconnected healthcare markets.
Outside of his professional responsibilities, Dr. Abujoub values balance, personal growth, and lifelong learning. His interests in biking, hiking, gardening, and reading reflect a grounded and disciplined lifestyle centered around wellness and curiosity. Guided by his personal motto, “Live Life to Its Full Potential,” he approaches both leadership and life with energy, optimism, and purpose. As he transitions from full-time executive leadership into broader board and advisory opportunities, he remains motivated by the opportunity to contribute his decades of experience to organizations seeking strategic guidance, operational discipline, and transformational leadership.
Dr. Abujoub’s career reflects a rare combination of scientific expertise, executive leadership, operational execution, and strategic vision. Having contributed to multiple successful product approvals, commercialization efforts, and organizational transformations, he brings boards a highly valuable perspective on governance, growth, compliance, innovation, and risk management. His ability to navigate complexity while maintaining a clear focus on people, performance, and long-term value creation positions him as a highly impactful addition to healthcare, biotechnology, manufacturing, and life sciences boards seeking experienced leadership in a rapidly evolving global industry.
Character:
Dr. Abujoub consistently demonstrates integrity, accountability, and resilience throughout every stage of his career. He is known for building cultures rooted in trust, collaboration, and personal responsibility while maintaining exceptionally high standards of professionalism. His leadership style reflects humility, discipline, and a sincere commitment to helping organizations and individuals reach their highest potential.
Knowledge:
He possesses deep expertise across gene therapy, biologics manufacturing, quality systems, CMC development, regulatory affairs, and global supply chain management. His extensive experience working with international regulatory agencies and leading complex manufacturing operations gives him a comprehensive understanding of the life sciences industry. He combines strong scientific acumen with operational insight, allowing him to make informed decisions that support both innovation and compliance.
Strategic:
Dr. Abujoub has repeatedly demonstrated the ability to lead organizations through transformation, commercialization, and operational scale-up. He understands how to align technical operations, quality systems, manufacturing strategy, and regulatory planning with long-term corporate objectives. His forward-thinking leadership approach enables organizations to anticipate risk, strengthen infrastructure, and position themselves for sustainable growth in highly competitive markets.
Communication:
A highly effective communicator who excels at translating complex scientific and operational issues into clear strategic insights for executive teams and boards. He fosters collaboration across multidisciplinary teams and global stakeholders through transparency, clarity, and mutual respect. His ability to engage with scientists, regulators, executives, and operational leaders alike has been instrumental in building strong partnerships and driving organizational success.
